The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1270 articles
After struggling with obesity for decades despite top advice, the author found lasting success by focusing on bodily mechanisms like insulin control. Key strategies include prioritizing fiber-rich foods, avoiding processed items, and ensuring protein in every meal. Health tracking apps like Shotlee can help monitor progress along the way.
Numerous individuals achieving weight reduction on GLP-1 agonists encounter challenges in ceasing the treatments, as appetite surges and weight rebounds. Studies indicate significant regain for those stopping, prompting some to view obesity as a chronic issue requiring ongoing medication. However, adopting healthier habits can help maintain losses post-treatment.
Beverley Callard, a beloved Coronation Street actress, took to social media to debunk rumors about using Ozempic for her weight loss. She emphasized her lifelong dedication to exercise and respect for individual choices. Fans praised her approach, and details on her fitness routines were highlighted alongside explanations of the medication.
Many people turn to GLP-1 drugs like Ozempic for weight loss, but cost can be a barrier. Affordable alternatives like berberine offer hope, yet experts caution against unrealistic hype. This article examines its benefits, side effects, and potential as a weight loss aid.
As new health goals emerge in January, weight loss medications like Mounjaro gain popularity, but an NHS notice warns about potential interactions with birth control and hormone therapy. Estimates indicate hundreds of thousands are using these drugs privately, with guidelines stressing extra precautions for absorption issues.
In 2025, the FDA approved 46 novel therapeutic agents from its Center for Drug Evaluation and Research, marking a slight dip from the five-year average but remaining above historical norms. Cancer led approvals, with advancements in modalities like kinase inhibitors and gene therapies. The year also introduced new programs and faced staffing challenges under changing leadership.
Health Canada acknowledges public demand for cheaper generic options for the popular drug Ozempic. Several companies have filed for authorization, though timelines are unclear. Patients may face delays in accessing these alternatives.
A recent study reveals that GLP-1 medications can significantly decrease severe asthma episodes among adolescents who are overweight or obese. Researchers found a notable reduction in emergency room visits and steroid use. Experts suggest these drugs offer dual benefits for weight control and asthma management.
Singer Jelly Roll achieved remarkable weight loss without relying on medications, choosing instead to address his eating habits as an addiction. He explains the surprising factors behind his decision and the profound impacts on his life. This natural path has revitalized his health and relationships.
